1. Introduction {#sec1}
===============

Regulation of food intake and energy consumption is a complex system that includes multiple regulations of brain and peripheral organs [@bib1], [@bib2], [@bib3], [@bib4]. As a group of lipid messengers, endocannabinoids (eCBs) have the capability to induce synaptic plasticity by retrograde modulation of glutamatergic and GABAergic neurotransmission in various brain areas as well as represent important metabolic signaling molecules in peripheral organs [@bib1], [@bib5], [@bib6]. Indeed, cannabinoid type 1 receptors (CB~1~R) are well known to mediate the effects of cannabinoids on energy metabolism [@bib7], [@bib8], [@bib9], [@bib10]. Novel data indicate that the anorexigenic proopiomelanocortin (POMC) neurons reverse their function in the presence of cannabinoids [@bib11], [@bib12]. However, the cellular and molecular mechanisms behind hypothalamic CB~1~R activation in order to regulate energy expenditure and feeding behavior are still not fully understood [@bib10], [@bib13]. POMC neurons affect whole body energy metabolism in tandem with neurons in the hypothalamic arcuate nucleus (ARC) that co-express Agouti-related protein (AgRP) and neuropeptide Y (NPY; [@bib14]). At times of negative energy balance, AgRP/NPY neurons are directly activated by the appetite-inducing hormone ghrelin and by increased levels of free fatty acids that are utilized in these neurons via beta-oxidation [@bib15]. Upon activation, AgRP/NPY neurons release neuropeptides as well as GABA to control behavior, in part by inhibiting POMC neurons in the ARC [@bib16]. In parallel to the feeding-promoting hormone ghrelin, distinct eCBs such as 2-arachodonoylglycerol (2-AG) are up regulated in the hypothalamus during fasting, whereas satiety-promoting hormones such as leptin acutely reduce hypothalamic 2-AG levels [@bib7], [@bib17], [@bib18]. This prandial state-dependent fluctuation of the retrograde messenger 2-AG indicates that eCBs might be involved in regulation of hypothalamic AgRP/NPY neurons. Previous studies demonstrated moderate amounts of radioactive CB~1~R ligand binding as well as CB~1~R mRNA in hypothalamic nuclei [@bib13], [@bib19], [@bib20], [@bib21]. However, AgRP/NPY neurons do not contain CB~1~R mRNA and it is thus unlikely that cannabinoids directly affect the output synapses of AgRP/NPY neurons [@bib19]. Nevertheless, retrograde eCB modification of presynaptic CB~1~R on glutamatergic or GABAergic axon terminals innervating AGRP/NPY neurons was suggested as a putative mechanism of eCB-dependent control of AgRP/NPY activity, but CB~1~R immunolabeling remained uncertain in the ARC [@bib6], [@bib22], [@bib23], [@bib24]. This inspired our immunohistochemical investigation of eCB signaling in the ARC. Here, we used transgenic mouse models and methods of electron microscopy combined with three-dimensional (3D) reconstruction from serial sections to evaluate the morphological substrate of presynaptic CB~1~R-dependent control of AgRP/NPY neurons in the ARC.

2. Methods {#sec2}
==========

2.1. Animal maintenance {#sec2.1}
-----------------------

Mice were maintained with water and food freely available and housed on a 12 h light/12 h dark cycle. All mice were aged between 12 and 16 weeks at the time of killing. Procedures were approved by the Institutional Animal Care and Use Committee of Yale University.

2.2. Transgenic animals {#sec2.2}
-----------------------

CB~1~R-null (CB1R^−/−^) mice were on a C57/BL6 background [@bib25]. NPY-GFP (B6.Cg-Tg(Npy-MAPT/Sapphire)1Rck/J, stock no 008321, The Jackson Laboratories, Bar Harbor, ME USA) and NPY-hrGFP (B6.FVB-Tg(Npy-hrGFP)1Lowl/J, stock no 006417, The Jackson Laboratories) mice were used for identification of AgRP/NPY neurons in the ARC. Both lines were maintained on a C57/BL6 background.

2.3. Immunohistochemistry for electron and light microscopy {#sec2.3}
-----------------------------------------------------------

For correlative light/electron microscopy, CB~1~R^+/+^, CB1R^+/−^, CB1R^−/−^ and NPY-GFP mice were perfused transcardially with a fixative containing 4% paraformaldehyde, 0.2% picric acid, and 0.2% glutaraldehyde in 0.1 M PB. The brains were removed and immersed overnight in the same fixative. Coronal brain sections (of 50 μm thickness) were cut with a vibratome. About half of the brain sections were immersed in 0.5% H~2~O~2~ for 30 min to block tissue peroxidase, whereas the remaining specimens were used for immunohistochemistry omitting this step. No difference in the immunolabeling was observed between these sections. For single immunolabeling, the sections were incubated with polyclonal sera against CB~1~R raised in guinea pig (1:1000; CB1-GP-Af530; Frontier Institute, Ishikari, Hokkaido, Japan), then, with biotinylated anti-guinea pig IgGs (1:300; Jackson Immunoresearch, West Grove, PA, USA) and the Elite ABC kit (Vector Laboratories, Burlingame, CA, USA) with Ni-intensified 3,3ʹ-diaminobenzidine-4HCl (DAB-Ni) as a chromogen. For CB~1~R/GFAP and CB~1~R/NPY-GFP double labeling, the sections were first immunolabeled for CB~1~R as above with DAB-Ni as a chromogen that produces intensive black staining; then, the sections were incubated with made-in-rat anti-GFAP (1:6000; Invitrogen, Eugene, OR, USA) or made-in-chicken anti-GFP (1:2000; Thermo Fisher Scientific, Rockford, IL, USA) sera. Thereafter, corresponding biotinylated anti-rat or anti-chicken IgGs (1:300; both from Jackson Immunoresearch) and the Elite ABC kit were applied as above. 3,3ʹ-diaminobenzidine-4HCl (DAB) producing diffuse electron-dense staining was used as a chromogen. The sections were post-fixed with 1% OsO~4~, dehydrated, embedded in durcupan (Fluka, Buchs, Switzerland) on microscope slides, and coverslipped. Selected fragments of tissue were analyzed and photographed with an Axioplan 2 microscope (Zeiss, Jena, Germany) and re-embedded into durcupan blocks for electron microscopic investigation. The samples were cut with a Reichert ultramicrotome into 70-nm-thick sections. The sections were then stained with lead citrate and evaluated and photographed in a JEM 1010 electron microscope (JEOL, Japan) equipped with a Multiscan 792 digital camera (Gatan, Pleasanton, CA, USA).

For 3D reconstruction, 20--30 serial images were made with 15,000× magnification of electron microscope. Neuropil fragments were chosen for the 3D reconstruction of axon-like processes in a random manner while avoiding cell bodies and blood vessels when possible. The micrographs were aligned using the computer program Reconstruct [@bib26], publicly available at <http://www.bu.edu/neural/Reconstruct.html>.

For fluorescent microscopy, NPY-hrGFP mice were perfused with 4% paraformaldehyde and 0.2% picric acid in 0.1 M PB. The brains were removed and immersed overnight in the same fixative. Coronal brain sections (of 50 μm thickness) were cut with a vibratome. For double immunofluorescence staining, the sections were incubated in blocking solution (5% normal goat serum and 0.2% Triton X-100 in 0.1 M PB) for 60 min. The primary polyclonal antibodies (guinea pig anti-CB~1~R IgG (CB1-GP-Af530); Frontier Institute, Ishikari, Hokkaido, Japan) and rabbit anti-diacylglycerol lipase-alpha (DAGL) IgG (DGLa-Rb-Af380; Frontier Institute) were both diluted at 1:300 and concomitantly applied overnight at room temperature. The next day, sections were washed 3 times in 0.1 M PB and were concomitantly incubated with the secondary antibodies (goat anti-guinea pig IgG (H+L) Alexa Fluor^®^ 568 conjugate, A-11075; and, goat anti-rabbit IgG (H+L) Alexa Fluor^®^ 633 conjugate; both from Thermo Fischer Scientific, Waltham, MA, USA) both at a dilution of 1:500 for 1 h at room temperature. Finally, the sections were coverslipped in DAKO mounting medium and confocal laser scanning microscopy was performed using a Zeiss LSM Meta 510.

In previous studies, we extensively analyzed specificity of the anti-CB~1~R labeling using mass-spectrometry, Western Blots, and immunohistochemistry at light and electron microscopy levels; we demonstrated that anti-CB~1~R IgG (CB1-GP-Af530; Frontier Institute) in parallel to CB~1~R also recognize a conformational epitope in mitochondrial stomatin-like protein 2 [@bib27], [@bib28], [@bib29]. Specific anti-DAGL labeling (neuronal somato-dendritic surface expression) was confirmed for immunohistochemistry at levels of light and electron microscopy using wild type and DAGL-null mice [@bib30], [@bib31], [@bib32]. Specific anti-GFP and anti-GFAP labeling was confirmed in numerous studies \[e.g., [@bib33], [@bib34]\].

2.4. Statistical analysis {#sec2.4}
-------------------------

Quantifications of the anti-CB~1~R immunolabeling in identified cell segments and organelles in ARC of the CB~1~R-expressing (CB~1~R^+/+^ and CB~1~R^+/−^, pooled) and CB~1~R^−/−^ mice were performed at 15,000× magnification of electron microscope. Percentages of the anti-CB~1~R immuno-precipitation locations in axon-like, dendro-somatic, and mitochondrial profiles were calculated for every measurement. Then, averages of 4 measurements from every one of 4 animals in each group ±SD were calculated using Excel 2013 (Microsoft) software.

3. Results {#sec3}
==========

3.1. CB~1~R concentrates in axon-like processes in the ARC {#sec3.1}
----------------------------------------------------------

Raised in guinea pig anti-CB~1~R serum provides intensive staining of CB~1~R-expressing cell bodies and axons in the cerebral cortex and hippocampus ([Supplementary Figure 1](#appsec2){ref-type="sec"}) that is similar to the immunolabeling obtained with other CB~1~R antibodies \[e.g., [@bib35], [@bib36], [@bib37]\]. In contrast, anti-CB~1~R labeling in the hypothalamus appears as sporadic immunopositive particles that are difficult to distinguish from background staining solely based upon light microscopy or qualitative electron microscopy ([Figure 1](#fig1){ref-type="fig"}A--D). Nevertheless, 3D reconstruction from serial sections reveals a dramatic difference in anti-CB~1~R labeling between CB~1~R-expressing and CB~1~R^−/−^ animals. We found that each CB~1~R-immunopositive process contains several discontinued depositions of anti-CB~1~R DAB-Ni immuno-precipitation in the CB~1~R wild type (CB~1~R^+/+^) and heterozygous (CB~1~R^+/−^) mice. In contrast, only a single spot of staining was detected in every 3D-reconstructed process in CB~1~R^−/−^ mice, designating occasional binding of the antibodies ([Figure 1](#fig1){ref-type="fig"}E, F).

Additional evidence of selective labeling in the CB~1~R-expressing animals was obtained with quantification of the sites of DAB-Ni immuno-precipitations in electron microscopy. Analysis of occasional single ultrathin sections shows that 82.2 ± 4.2% of the immuno-precipitations in the CB~1~R-expressing mice are located in axon-like processes, whereas the remaining number of immuno-precipitations is distributed between dendrites, cell bodies, and mitochondria ([Figure 1](#fig1){ref-type="fig"}G). Predomination of a certain location of anti-CB~1~R labeling was not encountered in CB~1~R^−/−^ mice. In those, non-CB~1~R binding of the CB~1~R antibodies (presumed background or labeling of other molecules) was detected in nearly equal proportions in axon-like processes, dendro-somatic cell segments, and mitochondria ([Figure 1](#fig1){ref-type="fig"}H). Mind that similar mitochondrial labeling is evident in the CB~1~R-expressing and CB~1~R^−/−^ mice, confirming previously demonstrated binding of the anti-CB~1~R serum with mitochondrial stomatin-like protein 2 rather than revealing mitochondrial location of CB~1~R [@bib27], [@bib28], [@bib29].

In three random segments of ARC neuropil from CB~1~R^+/+^ mice that were subject of electron microscopy analysis and 3D reconstruction (each analyzed volume ∼100 μm^3^), we identified in total 32, 26, and 13 CB~1~R-positive axon-like processes per a reconstructed segment ([Supplementary Figure 2](#appsec2){ref-type="sec"}). No dendrite-like processes containing CB~1~R accumulation were observed in these neuropil segments. Detected CB~1~R-positive axon-like processes are separated by immunonegative tissue and do not form CB~1~R-enriched bundles that would be easily identifiable with light microscopy. Thus, our quantitative electron microscopy analysis and 3D reconstruction from serial sections demonstrate numerous CB~1~R-positive axon-like processes in the hypothalamus.

3.2. CB~1~R-expressing axons innervate AgRP/NPY-positive and -negative neurons {#sec3.2}
------------------------------------------------------------------------------

To analyze whether the hypothalamic CB~1~R-expressing axons could produce synapses innervating AgRP/NPY neurons in the ARC, we performed double immunolabeling for CB~1~R and GFP in the NPY-GFP transgenic mice. Using 3D reconstruction from serial sections, we detected CB~1~R-positive synapses innervating NPY-GFP-positive dendrites ([Figure 2](#fig2){ref-type="fig"}A--C). Among five identified synapses, all were of symmetric morphological type, indicating that inhibitory GABAergic inputs probably predominate among CB~1~R-positive synapses that innervate AgRP/NPY neurons. In contrast, NPY-GFP-negative dendritic shafts and cell bodies show both symmetric and asymmetric synaptic contacts with CB~1~R-immunopositive axons ([Figure 2](#fig2){ref-type="fig"}D, E and [Figure 3](#fig3){ref-type="fig"}). Thus, CB~1~R-containing synapses innervate AgRP/NPY and other neurons, supporting the hypothesis for retrograde eCB signaling in the ACR and predomination of eCB-conducted dis-inhibition of the AgRP/NPY hunger promoting neurons. Further morphological study (for example, immuno-gold labeling that provides more precise location of the antigen) of CB~1~R location in the hypothalamic nuclei is warranted.

3.3. CB~1~R and DAGL are co-localized at AgRP/NPY neurons in ARC {#sec3.3}
----------------------------------------------------------------

To further elucidate potential CB~1~R signaling in ARC, we performed immunofluorescence assay for the enzyme DAGL, which is known to be located at postsynaptic sites catalyzing biosynthesis of the eCB retrograde messenger 2-AG [@bib38], [@bib39]. We observed dotted DAGL immunolabeling as in GFP-expressing AgRP/NPY neurons so in GFP-negative cells. Multiple immunofluorescence exemplified a close spatial relationship between CB~1~R and DAGL in the ARC, particularly at NPY-GFP neurons ([Figure 4](#fig4){ref-type="fig"}). The latter finding supports a retrograde mode of action of 2-AG at AgRP/NPY neurons, as has been demonstrated in other brain segments [@bib5], [@bib29].

4. Discussion {#sec4}
=============

Relatively low anti-CB~1~R immuno-reactivity in the hypothalamus makes identification of CB~1~R-containing axons with light microscopy and in single electron micrographs difficult. Here, we addressed this problem using electron microscopy with 3D reconstruction from serial sections. We show that (1) numerous axons in ARC contain several discontinuous CB~1~R-positive segments; (2) CB~1~R-positive axons innervate AgRP/NPY neurons with mostly symmetric, presumed inhibitory, synapses; (3) unlabeled neurons receive both symmetric and asymmetric synaptic contacts with CB~1~R-positive axons; (4) DAGL -- the enzyme catalyzing biosynthesis of the eCB retrograde messenger 2-AG -- is in close apposition to CB~1~R at AgRP/NPY neurons. Taken together, the data demonstrate the morphologic substrate for eCB/CB~1~R-conducted retrograde dis-inhibition of the orexigenic neurons in ARC.

CB~1~R and eCBs were shown to be involved in the regulation of food intake and energy consumption in several hypothalamic nuclei, including the lateral and dorsomedial hypothalamus as well as ARC and paraventricular nucleus [@bib1], [@bib2], [@bib11], [@bib13], [@bib19], [@bib40], [@bib41]. Moreover, eCB prandial regulation apparently includes synaptic and non-synaptic mechanisms [@bib10], [@bib12], [@bib42]. A hypothalamic role of CB~1~R-containing synapses in eCB regulation of food intake was suggested [@bib19], [@bib22], but it was not experimentally demonstrated. Our findings unravel a yet unknown synaptic mechanism of eCB control of food intake that may act in parallel with recently demonstrated intracellular eCB control of mitochondrial respiration [@bib12].

Thus, our results show that eCBs and cannabis drugs may conduct prandial mechanisms through retrograde synaptic dis-inhibition and dis-excitation in the hypothalamus. Further investigations are warranted to determine the location and neurochemical properties of CB~1~R-expressing inhibitory neurons innervating AgRP/NPY neurons in ARC; and, to determine what neurons provide the CB~1~R-containing inputs to other neurons of the hypothalamus.
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Appendix A. Supplementary data {#appsec2}
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The following are the supplementary data related to this article:Supplementary Figure 1**Immunohistochemical labeling of CB**~**1**~**R in the hippocampal CA1 zone from CB**~**1**~**R**^**+/−**^**(A) and CB**~**1**~**R**^**−/−**^**(B) mice using made in guinea pig anti-CB**~**1**~**R serum.** Numerous CB~1~R-expressing cell bodies (arrows) and axons (arrowheads) are seen in **A**, whereas only sporadic dots representing non-CB~1~R labeling (empty arrowheads) are observed in **B**. Framed areas in A and B are enlarged in the insertions. (Scale bars in **A and B** = 50 μm; in the **insertions** = 10 μm).Supplementary Figure 1Supplementary Figure 2**Electron microscopy 3D reconstruction of CB**~**1**~**R-containing axon-like processes in ARC from CB**~**1**~**R**^**+/+**^**mouse.** Processes correspondingly numerated in **A** and **B** are rotated about 90° relative to each other. Reconstructed processes are depicted with distinct semitransparent colors, and intracellular anti-CB~1~R DAB-Ni depositions are shown in black. Notice that most of the axons are parallel to each other and are vertical to the plane of coronal sectioning performed in this sampling. Synaptic-like varicosities are indicated with arrows. Immunonegative cells are not shown here. (Scale bars = 1 μm).Supplementary Figure 2
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Supplementary data related to this article can be found at [http://dx.doi.org/10.1016/j.molmet.2017.01.004](10.1016/j.molmet.2017.01.004){#intref0015}.

![**Light and electron microscopy of the hypothalamus from CB**~**1**~**R-expressing mice and CB**~**1**~**R**^**−/−**^**littermates immunolabeled with anti-CB**~**1**~**R serum**. (**A and B**) Representative light micrographs of ARC from CB~1~R^+/−^ (**A**) and CB~1~R^−/−^ mice (**B**). Equal conditions of the tissue and micrograph preparation were applied. The micrographs show numerous immunopositive particles (arrows) in CB~1~R^+/−^ and similar but relatively rare staining in CB~1~R^−/−^. (**C and D**) Electron microscopy analysis shows that, in the CB~1~R^+/−^, numerous immunolabeling depositions are located in thin axon-like processes (arrows); atypical staining is also present. For example, it is unclear whether the DAB-Ni deposition between the axonal cell membrane and mitochondria (empty arrow) results from selective labeling of membranous CB~1~R or cross reactivity with mitochondrial stomatin-like protein 2 [@bib27], [@bib28], [@bib29]. Electron micrograph from CB~1~R^−/−^ shows non-selective DAB-Ni deposition in a dendrite (empty arrowhead) and mitochondrial labeling characteristic for stomatin-like protein 2 (double arrow). (**E and F**) 3D reconstructions from serial ultrathin sections of arbitrarily chosen axon-like processes (each depicted with different colors in semitransparent mode) that contain DAB-Ni depositions (depicted black; arrows). The processes in CB~1~R^+/−^ contain numerous immunopositive fragments, whereas axon-like processes contain single spots of DAB-Ni deposition in CB~1~R^−/−^. Red line in E indicates positioning of the profiles shown in the electron micrograph in C where they are highlighted with the same semitransparent colors, respectively. (**G and H**) Electron microscopy quantifications of the anti-CB~1~R immunolabeling in identified cell segments and organelles in ARC of the CB~1~R-expressing (CB~1~R^+/+^ and CB~1~R^+/−^, pooled) and CB~1~R^−/−^ mice. Notice that anti-CB~1~R immunolabeling predominates in the axon-like processes in the CB~1~R-expressing animals (**G**); this is not encountered in CB~1~R^−/−^ mice (**H**). This confirms presence of CB~1~R in the axons while dendro-somatic and mitochondrial CB~1~R locations are enigmatic. Averages of the measurements from 4 animals in each group ±SD are indicated. Abbreviations: d, dendrite; sb, synaptic bouton. (Scale bars in **A and B** = 10 μm; in **C--F** = 0.5 μm).](gr1){#fig1}

![**CB**~**1**~**R in synaptic boutons innervating AgRP/NPY-positive and -negative neurons in the ARC**. (**A--C**) In 3D reconstruction, NPY-GFP-positive dendritic shaft (yellow) contacts with CB~1~R-positive axon (blue). Positions of profiles shown in electron micrographs (**B and C**) are indicated with red dotted lines b and c, respectively. (**B**) NPY-GFP-positive dendrite identified with diffuse DAB deposition (highlighted semitransparent yellow) produces symmetric synapse (arrowhead) with CB~1~R-positive synaptic bouton (semitransparent blue) that is identified with intense black DAB-Ni staining. (**C**) The NPY-GFP-positive dendrite is also innervated by two symmetric synapses (arrowheads) from CB~1~R-negative axons. Profile of axonal shaft of the reconstructed CB~1~R-positive axon is indicated with empty arrow. Profiles of other CB~1~R-positive axons not shown in the 3D reconstructions are also seen (arrows in **C**). (**D and E**) 3D reconstruction from serial ultrathin sections demonstrates three axons (each depicted with different colors in semitransparent mode) that contain plural anti-CB~1~R DAB-Ni depositions (depicted black; small arrows) and innervate NPY-GFP-negative cells. Red dotted lines indicate positioning of the profiles shown in the electron micrograph in **E** where they are highlighted with the same semitransparent colors, respectively. The yellow synaptic bouton produces symmetric synapse (arrowhead) with the NPY-GFP-negative cell body (semitransparent orange). The green synaptic bouton produces asymmetric synapses (empty arrowheads) with, the NPY-GFP-negative cell body and a dendrite. Several CB~1~R-positive axon-like profiles (not shown in 3D) are highlighted semitransparent red. (Scale bars = 1 μm).](gr2){#fig2}

![**A three-somatic synapse in ARC from CB**~**1**~**R**^**+/+**^**mouse identified with double immunolabeling for CB**~**1**~**R (DAB-Ni) and GFAP (DAB) combined with electron microscopy 3D reconstruction**. (**A and B**) 3D reconstruction images rotated 90° relative to each other. (**C and D**) Representative serial micrographs used for the 3D reconstruction. CB~1~R-containing synaptic bouton (depicted semitransparent yellow in 3D and serial electron micrographs) innervates an immunonegative dendritic shaft (depicted semitransparent indigo). The synaptic contact is shown in red in 3D and indicated with red arrowheads in the electron micrographs. Anti-CB~1~R intensive black DAB-Ni depositions (arrows; depicted black in 3D) are seen in both, the synaptic bouton and axonal shafts. Another CB~1~R-containing axon-like process (semitransparent yellow; empty arrows) is also seen. Notice that several of the anti-CB~1~R DAB-Ni depositions (arrows) contact the GFAP-positive astroglial cell (identified with diffuse DAB staining; highlighted semitransparent light blue), but they are not inside of it. (Scale bars = 0.5 μm).](gr3){#fig3}

![**Immunolabeling for CB**~**1**~**R (red) and DAGL (blue) in ARC from the NPY-hrGFP transgenic mouse**. CB~1~R/DAGL-double positive spots \[some of those are at NPY-hrGFP-expressing cells (green)\] are indicated with arrows. CB~1~R-positive DAGL-negative spots are indicated with arrowheads. (Scale bar = 10 μm).](gr4){#fig4}
